Products
Technologies
Applications
Services
Resources
Selection Guides
About
Matrix metalloproteinase 13 Inhibitors (IC50, Ki)
Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
 | (2R)-N-Hydroxy-2-[(4-methoxyphenyl)sulfonyl-(pyridin-3-ylmethyl)amino]-3-methylbutanamide;hydrochloride | IC50 | 8.0 [1] |
| (2R)-N-Hydroxy-2-[(4-methoxyphenyl)sulfonyl-(pyridin-3-ylmethyl)amino]-3-methylbutanamide;hydrochloride | Ki | 1.27 [1] |
 | 4-[4-(4-Chloro-phenoxy)-benzenesulfonylmethyl]-tetrahydro-pyran-4-carboxylic acid hydroxyamide | IC50 | 0.3 [1] |
| 4-[4-(4-Chloro-phenoxy)-benzenesulfonylmethyl]-tetrahydro-pyran-4-carboxylic acid hydroxyamide | Ki | 0.28 [1], 0.52 [2] |
 | Marimastat | IC50 | 2.0 [1] |
References
This online resource may be cited as follows
MLA | "Quest Database™ Matrix metalloproteinase 13 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 20 Jan. 2026, https://www.aatbio.com/data-sets/matrix-metalloproteinase-13-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2026, January 20). Quest Database™ Matrix metalloproteinase 13 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/matrix-metalloproteinase-13-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |